Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| gamma-Cyclodextrins | 2 | 2020 | 2 | 1.400 |
Why?
|
| Cholesterol | 3 | 2020 | 205 | 1.390 |
Why?
|
| Niemann-Pick Disease, Type C | 3 | 2020 | 5 | 1.010 |
Why?
|
| Lysosomes | 2 | 2020 | 91 | 0.860 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 105 | 0.690 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 187 | 0.670 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2017 | 159 | 0.270 |
Why?
|
| beta-Cyclodextrins | 2 | 2018 | 24 | 0.200 |
Why?
|
| Hela Cells | 2 | 2018 | 366 | 0.190 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2020 | 17 | 0.180 |
Why?
|
| Vesicular Transport Proteins | 1 | 2020 | 42 | 0.180 |
Why?
|
| Biological Transport | 1 | 2020 | 185 | 0.180 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 803 | 0.170 |
Why?
|
| Proteomics | 2 | 2018 | 325 | 0.170 |
Why?
|
| Autophagy | 1 | 2020 | 116 | 0.170 |
Why?
|
| Endosomes | 1 | 2018 | 36 | 0.160 |
Why?
|
| Cyclodextrins | 1 | 2018 | 10 | 0.160 |
Why?
|
| Carrier Proteins | 1 | 2020 | 305 | 0.160 |
Why?
|
| Cell Line | 2 | 2018 | 1354 | 0.150 |
Why?
|
| Minority Groups | 1 | 2023 | 596 | 0.150 |
Why?
|
| Protein Transport | 1 | 2018 | 302 | 0.150 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2017 | 5 | 0.150 |
Why?
|
| Fibrosarcoma | 1 | 2017 | 8 | 0.150 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2017 | 16 | 0.150 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 20 | 0.150 |
Why?
|
| Multiple Myeloma | 1 | 2017 | 39 | 0.140 |
Why?
|
| Infant | 1 | 2020 | 1046 | 0.140 |
Why?
|
| Dendritic Cells | 1 | 2017 | 113 | 0.140 |
Why?
|
| Kidney Neoplasms | 1 | 2017 | 68 | 0.140 |
Why?
|
| Cells, Cultured | 1 | 2020 | 1518 | 0.140 |
Why?
|
| Proteins | 1 | 2018 | 369 | 0.130 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 2231 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 251 | 0.120 |
Why?
|
| Cytokines | 1 | 2017 | 602 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 358 | 0.110 |
Why?
|
| Child | 1 | 2020 | 3131 | 0.100 |
Why?
|
| Humans | 5 | 2023 | 37093 | 0.090 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2017 | 114 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 1502 | 0.070 |
Why?
|
| Female | 2 | 2020 | 20969 | 0.060 |
Why?
|
| Male | 1 | 2020 | 20025 | 0.050 |
Why?
|
| Universities | 1 | 2023 | 442 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2018 | 79 | 0.040 |
Why?
|
| Membrane Lipids | 1 | 2018 | 33 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2018 | 43 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2017 | 1908 | 0.040 |
Why?
|
| Students | 1 | 2023 | 519 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 119 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 2017 | 12 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 24 | 0.040 |
Why?
|
| Tumor Escape | 1 | 2017 | 13 | 0.040 |
Why?
|
| STAT5 Transcription Factor | 1 | 2017 | 46 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 148 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2018 | 492 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 661 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 864 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 269 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 617 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2017 | 339 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1015 | 0.030 |
Why?
|
| Animals | 2 | 2017 | 15081 | 0.020 |
Why?
|
| Mice | 1 | 2017 | 5913 | 0.020 |
Why?
|